NEWS
![[Edaily] C&R Research And Pharos IBio: Advancing As Key Partners In AI-Driven Drug Development](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Edaily] C&R Research and Pharos iBio: Advancing as Key Partners in AI-Driven Drug Development
2025-03-12
C&R Research has signed a contract to conduct a Phase 1 clinical trial for 'PHI-501', an investigational drug being developed…
[Yakup] C&R Research attracts attention with its ‘first dividend’ since establishment
2025-02-13
C&R Research announced that it has finalized a dividend of KRW 10 per share, totaling KRW 570 million, for 56,725,420…
[FNNews] C&R Research expands globally through CRO business
2024-12-24
Growth Research assessed that C&R Research has the potential to expand its global influence through its Clinical Research Organization (CRO)…
[Yakup] C&R Research selected as a “2024 Best Work-Life Balance Company” in Korea
2024-12-11
C&R Research selected as a "2024 Best Work-Life Balance Company" in Korea! "2024 Best Work-Life Balance Company" was newly…
[Yakup] C&R Healthcare Global (Thailand), the Thai subsidiary of C&R Research, and KIMCo signed an MOU to ‘Develop TBM in the ASEAN region’
2024-12-04
C&R Healthcare Global (Thailand) Co., Ltd., the Thai subsidiary of C&R Research, and KIMCo(Korea Innovative Medicines Consortium) signed an MOU…